Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Total Hip Arthroplasty
NCT02607462Unknown
- Sponsor
- Satakunta Central Hospital
- Start
- Nov 2015
- Primary completion
- Oct 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma in hip osteoarthritis (2 arms), sponsored by Satakunta Central Hospital. Primary endpoint: Decrease of T2 weighted signaling between PRP and placebo group at 12 months. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT02607462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607462.